Nashville Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Nashville Biosciences's estimated annual revenue is currently $5M per year.
- Nashville Biosciences's estimated revenue per employee is $155,000
Employee Data
- Nashville Biosciences has 32 Employees.
- Nashville Biosciences grew their employee count by 14% last year.
Nashville Biosciences's People
Name | Title | Email/Phone |
---|
Nashville Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | 0% | N/A | N/A |
#2 | $5M | 32 | 14% | N/A | N/A |
#3 | $3.6M | 23 | 5% | N/A | N/A |
#4 | $1.1M | 7 | -22% | N/A | N/A |
#5 | $1.7M | 11 | 0% | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $6M | 39 | 50% | N/A | N/A |
#8 | $0.9M | 6 | 0% | N/A | N/A |
#9 | $4.8M | 31 | -6% | N/A | N/A |
#10 | $1.9M | 12 | 0% | N/A | N/A |
What Is Nashville Biosciences?
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.
keywords:N/AN/A
Total Funding
32
Number of Employees
$5M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 32 | 10% | N/A |
#2 | $3.8M | 32 | 7% | N/A |
#3 | N/A | 32 | 14% | N/A |
#4 | $7.5M | 32 | -18% | N/A |
#5 | $5.4M | 32 | 7% | N/A |